1. Home
  2. AVTX vs MNTX Comparison

AVTX vs MNTX Comparison

Compare AVTX & MNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • MNTX
  • Stock Information
  • Founded
  • AVTX 2011
  • MNTX 1993
  • Country
  • AVTX United States
  • MNTX United States
  • Employees
  • AVTX N/A
  • MNTX N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • MNTX Industrial Machinery/Components
  • Sector
  • AVTX Health Care
  • MNTX Technology
  • Exchange
  • AVTX Nasdaq
  • MNTX Nasdaq
  • Market Cap
  • AVTX 90.9M
  • MNTX 77.7M
  • IPO Year
  • AVTX 2015
  • MNTX 2005
  • Fundamental
  • Price
  • AVTX $10.13
  • MNTX $5.74
  • Analyst Decision
  • AVTX Buy
  • MNTX Hold
  • Analyst Count
  • AVTX 2
  • MNTX 1
  • Target Price
  • AVTX $35.00
  • MNTX $5.80
  • AVG Volume (30 Days)
  • AVTX 59.3K
  • MNTX 117.4K
  • Earning Date
  • AVTX 11-07-2024
  • MNTX 11-07-2024
  • Dividend Yield
  • AVTX N/A
  • MNTX N/A
  • EPS Growth
  • AVTX N/A
  • MNTX 248.43
  • EPS
  • AVTX N/A
  • MNTX 0.46
  • Revenue
  • AVTX $820,000.00
  • MNTX $294,775,000.00
  • Revenue This Year
  • AVTX N/A
  • MNTX $6.97
  • Revenue Next Year
  • AVTX N/A
  • MNTX $12.08
  • P/E Ratio
  • AVTX N/A
  • MNTX $12.49
  • Revenue Growth
  • AVTX N/A
  • MNTX 1.10
  • 52 Week Low
  • AVTX $3.95
  • MNTX $3.07
  • 52 Week High
  • AVTX $34.46
  • MNTX $9.16
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 37.71
  • MNTX 62.19
  • Support Level
  • AVTX $12.00
  • MNTX $5.69
  • Resistance Level
  • AVTX $13.59
  • MNTX $5.76
  • Average True Range (ATR)
  • AVTX 0.96
  • MNTX 0.03
  • MACD
  • AVTX -0.50
  • MNTX -0.01
  • Stochastic Oscillator
  • AVTX 17.42
  • MNTX 63.64

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About MNTX Manitex International Inc.

Manitex International Inc through its subsidiaries is engaged in the design, manufacture, and distribution of engineered lifting solutions. Its products include boom trucks, truck cranes, and sign cranes. The company's segments include Lifting Equipment and Rental Equipment. It generates maximum revenue from the Lifting Equipment segment. Geographically, it derives majority of its revenue from the United States.

Share on Social Networks: